Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty

Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty

The administration of zoledronic acid (ZA) to patients who received cementless total hip arthroplasty (THA) has been reported to reduce bone turnover markers (BTMs) and increase bone mineral density (BMD). The effects of two-dose ZA versus placebo on cementless THA patients were analyzed in this fiv...

Full description

Bibliographic Details
Main Authors: Allen Herng Shouh Hsu, Chun-Hsien Yen, Feng-Chih Kuo, Cheng-Ta Wu, Tsan-Wen Huang, Juei-Tang Cheng, Mel S. Lee
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Pharmaceuticals
Subjects:
bisphosphonate
zoledronic acid
total hip arthroplasty
bone mineral density
bone turnover marker
Online Access:https://www.mdpi.com/1424-8247/15/4/420

Similar Items

Similar Items